Physician profile
Gregory Wayne Proctor
NPI 1326305558
$1,657.49
in general payments reported to CMS, 2019-2025
16 companies · $33.11 in 2025
The $33.11 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $252 · 2021: $452 · 2022: $29.45 · 2023: $47.48 · 2025: $33.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $426.59 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $288.19 | 2019-2022 | |
| Opko Pharmaceuticals, LLC | $177.84 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $166.05 | 2019-2023 | Ultomiris |
| Horizon Therapeutics Plc | $150.83 | 2019 | |
| Vifor Pharma, INC. | $137.28 | 2019-2021 | |
| Glaxosmithkline, LLC. | $64.05 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.29 | 2021 | |
| Janssen Pharmaceuticals, INC | $36.63 | 2019-2023 | Xarelto |
| Abbvie INC. | $33.11 | 2025 | |
| Fresenius USA Marketing, INC. | $32.95 | 2019 | |
| Mallinckrodt Enterprises LLC | $24.01 | 2019 | |
| Mallinckrodt Hospital Products INC. | $19.30 | 2021 | |
| Daiichi Sankyo INC. | $17.86 | 2019 | |
| Ethicon US, LLC | $17.71 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Proctor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.